Virtual or in person, we participate in many conferences as speakers, exhibitors or as attendees. Let us know if you’d like to connect at any of the forthcoming meeting we’re attending.
Julia Shanu-Wilson will be giving a talk at the 5th RSC / DMDG / DMG New Perspectives in DMPK meeting taking place 22-23 February 2022. The title of Julia’s talk presentation is “One-Stop Metabolite Shop; Employing Multiple Tools for Accessing Drug Metabolites.”
Hypha will be participating in the DMDG’s 2nd European Biotransformation Workshop being held 24-25 November 2021. The purpose of this workshop is to provide a platform for biotransformation scientists to discuss topics of interest to them and the biotransformation community at large.
Julia Shanu-Wilson will be giving a talk at the Boston PBSS workshop on Radio-labeled Mass Balance and Metabolite Profiling Studies: Fundamentals, Best Practices, Regulatory Requirements, Applications and Case Studies.
Hypha are pleased to be sponsors of the Applied Pharmaceutical Analysis 2021 meeting being held virtually from 12-14 October 2021. At the meeting Julia Shanu-Wilson will be giving a talk on “Parallel synthesis of metabolites and late-stage oxidized derivatives of lead compounds: dual purpose application of PolyCYPs enzymes.”
Hypha will be exhibiting and presenting a poster on “Accessing Metabolites of the Drug Cenobamate: Challenges and Solutions” at the 2021 ISSX Meeting.
Frank Scheffler will be presenting at the 2021 EFMC International Symposium on Medicinal Chemistry meeting on “Integration of Biocatalysis into Medicinal Chemistry Programs for Late-Stage Oxidised Derivatives using PolyCYPs Enzymes”.
Liam Evans and Steve Wrigley will be giving a talk in the Metabolite and Process Impurity Identification for Early-Stage Discovery track at the ACS Fall 2021 meeting on “Comprehensive solutions for accessing metabolites of drugs and agrochemicals”.
Stay up to date with the latest news from Hypha Discovery
Sign up for our Newsletter to receive interesting updates and scientific case studies about Hypha’s metabolite generation capabilities and lead optimization solutions
Ready to begin? Our scientists are available to talk through your requirements
Hypha Discovery is a UK-based CRO supporting pharmaceutical and agrochemical companies worldwide through the production of metabolites and new derivatives of drugs and agrochemicals in discovery and development.